Innate Pharma (PK) (IPHYF) Notizie

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
14/05/2024	12:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:IPHYF	Innate Pharma (PK)
06/02/2024	23:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:IPHYF	Innate Pharma (PK)
26/06/2023	12:03	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:IPHYF	Innate Pharma (PK)
26/04/2023	22:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:IPHYF	Innate Pharma (PK)
06/04/2023	12:43	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:IPHYF	Innate Pharma (PK)
06/12/2022	17:53	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:IPHYF	Innate Pharma (PK)
25/09/2022	03:35	TipRanks	Kepler Capital Keeps Their Hold Rating on Innate Pharma SA (IPHYF)	USOTC:IPHYF	Innate Pharma (PK)
17/09/2022	03:51	TipRanks	Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Innate Pharma SA (OtherIPHYF)	USOTC:IPHYF	Innate Pharma (PK)
26/03/2022	02:40	TipRanks	Kepler Capital Thinks Innate Pharma SA’s Stock is Going to Recover	USOTC:IPHYF	Innate Pharma (PK)
12/07/2021	19:43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:IPHYF	Innate Pharma (PK)
16/01/2014	06:00	OTC Markets	Piggyback Qualified	USOTC:IPHYF	Innate Pharma (PK)

IPHYF